Rare Diseases
A Global Perspective
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Access a growing selection of included Audible Originals, audiobooks, and podcasts.
You will get an email reminder before your trial ends.
Audible Plus auto-renews for $7.95/mo after 30 days. Upgrade or cancel anytime.
Buy for $9.00
-
Narrated by:
-
Virtual Voice
-
By:
-
Richard Murch
This title uses virtual voice narration
Virtual voice is computer-generated narration for audiobooks.
This report examines the complex landscape of rare diseases, from the fundamental difficulties in diagnosis and treatment to the revolutionary technologies offering hope for patients and families.
The journey for rare disease patients is marked by profound challenges: an average diagnostic odyssey lasting five to seven years, limited treatment options with only about 5% of rare diseases having FDA-approved therapies, and astronomical costs that can exceed millions of dollars annually.
Yet, we stand at an unprecedented moment of scientific breakthrough, where technologies like CRISPR gene editing, RNA-based therapeutics, and artificial intelligence are transforming what was once impossible into reality.
This comprehensive overview explores both the remarkable success stories—from spinal muscular atrophy treatments that have saved countless infants to CRISPR-based cures for sickle cell disease—and the sobering failures that remind us of the work ahead.
The book concludes with actionable recommendations for the United States to strengthen its response to rare diseases and a vision for the future where every patient, regardless of how rare their condition, has access to accurate diagnosis, effective treatment, and compassionate care.
No reviews yet